BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
ByAinvest
Tuesday, Mar 10, 2026 7:33 am ET1min read
BCTX--
BriaCell Therapeutics Corp. will present four posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, highlighting research on its cellular immunotherapy platform, including a pivotal Phase 3 study of Bria-IMT and research on Bria-OTS+, a next-generation personalized off-the-shelf immunotherapy program. Poster titles and presentation details will be available on March 17, 2026. The company is a clinical-stage biotechnology firm developing novel immunotherapies to transform cancer care.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet